BACKGROUND: Decreased heart rate recovery (HRR) is a predictor of mortality in patients with coronary artery disease and preserved left ventricular function. We investigated the changes in HRR and assessed the impact of beta-blockade therapy on these parameters in patients with symptomatic congestive heart failure (CHF). METHODS AND RESULTS: HRR, defined as the difference from peak exercise heart rate (HR) to HR measured at 1, 2, and 3 minutes after maximal exercise test, was studied in 23 stable CHF patients and 12 healthy subjects. Patients with CHF performed a maximal exercise test using a Ramp protocol before and after 6 months of therapy with either metoprolol or carvedilol. Patients with CHF exhibited a significantly attenuated HRR compared with healthy subjects at 1 minute (17.8 +/- 5.8 versus 26.8 +/- 16.2 beats), 2 minutes (34.0 +/- 10.6 versus 48.0 +/- 11.2 bpm) and 3 minutes (41.0 +/- 12.4 versus 60.0 +/-12.4 bpm) after exercise (P<.05 for all parameters). Beta-blocker therapy for 6 months did not significantly improve HRR. CONCLUSION: HRR is markedly attenuated in stable CHF patients compared with healthy subjects. Long-term beta-blocker therapy appears to cause no significant improvement in HRR up to 3 minutes after maximal exercise.
BACKGROUND: Decreased heart rate recovery (HRR) is a predictor of mortality in patients with coronary artery disease and preserved left ventricular function. We investigated the changes in HRR and assessed the impact of beta-blockade therapy on these parameters in patients with symptomatic congestive heart failure (CHF). METHODS AND RESULTS: HRR, defined as the difference from peak exercise heart rate (HR) to HR measured at 1, 2, and 3 minutes after maximal exercise test, was studied in 23 stable CHFpatients and 12 healthy subjects. Patients with CHF performed a maximal exercise test using a Ramp protocol before and after 6 months of therapy with either metoprolol or carvedilol. Patients with CHF exhibited a significantly attenuated HRR compared with healthy subjects at 1 minute (17.8 +/- 5.8 versus 26.8 +/- 16.2 beats), 2 minutes (34.0 +/- 10.6 versus 48.0 +/- 11.2 bpm) and 3 minutes (41.0 +/- 12.4 versus 60.0 +/-12.4 bpm) after exercise (P<.05 for all parameters). Beta-blocker therapy for 6 months did not significantly improve HRR. CONCLUSION: HRR is markedly attenuated in stable CHFpatients compared with healthy subjects. Long-term beta-blocker therapy appears to cause no significant improvement in HRR up to 3 minutes after maximal exercise.
Authors: Richard J Sheppard; Normand Racine; Andre Roof; Anique Ducharme; Martine Blanchet; Michel White Journal: Can J Cardiol Date: 2007-12 Impact factor: 5.223
Authors: Vera Kubrychtova; Thomas P Olson; Kent R Bailey; Prabin Thapa; Thomas G Allison; Bruce D Johnson Journal: Eur J Appl Physiol Date: 2008-09-17 Impact factor: 3.078
Authors: Stuart A Best; Tiffany B Bivens; M Dean Palmer; Kara N Boyd; M Melyn Galbreath; Yoshiyuki Okada; Graeme Carrick-Ranson; Naoki Fujimoto; Shigeki Shibata; Jeffrey L Hastings; Matthew D Spencer; Takashi Tarumi; Benjamin D Levine; Qi Fu Journal: J Appl Physiol (1985) Date: 2014-10-09
Authors: Charalampos D Kriatselis; Sotirios Nedios; Sebastian Kelle; Sebastian Helbig; Martin Gottwik; Christian von Bary Journal: Cardiol Res Pract Date: 2012-01-24 Impact factor: 1.866